Anti-diabetic medications’ effect on outcomes and glycemic markers following TJA in patients with type 2 diabetes
Archives of Orthopaedic and Trauma Surgery · 2025
DOI: 10.1007/s00402-025-06160-9 ↗Kurz gefasst
Fachartikel in der Zeitschrift Archives of Orthopaedic and Trauma Surgery, 2025. Verfasst von Garrett Ruff und 5 weiteren Autor:innen. Beteiligte Einrichtung: New York University Langone Orthopedic Hospital, New York, USA. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, Hypoglycemic Agents, Surgical Wound Infection, Arthroplasty, Replacement, Knee. Die Arbeit nennt 44 Literaturangaben.
Themen: Diabetes mellitus
Abstract (Originalsprache)
INTRODUCTION: Diabetes is a known risk factor for surgical-site infection (SSI) following total joint arthroplasty (TJA), but the impact of antidiabetic medications on outcomes remains unclear. This study investigated the association between medication regimen, clinical outcomes, and glycemic control in patients with Type 2 diabetes (T2DM). METHODS: We retrospectively reviewed T2DM patients undergoing primary, elective TJA from 2011 to 2022. Patients were stratified by their antidiabetic medication regimen taken for at least one month in the year preoperatively: (1) one medication, (2) 2 + medications, and (3) insulin-containing regimen. Cohorts were matched by preoperative hemoglobin A1c (HbA1c), age, body-mass index (BMI), sex, and ASA class. Demographics, outcomes, and glycemic markers were compared. RESULTS: Of 2767 TJAs, 55.4%, 30.1%, and 14.5% fell into Cohorts 1, 2, and 3, respectively. After matching, each cohort included 273 procedures. Insulin-treated patients had greater blood glucose variability during hospitalization (153.7 vs. 114.8 [1] & 119.0 [2]; P < 0.001). Long-term outcomes, revision incidence, and SSIs did not differ significantly across cohorts. In regression of the pre-match population, insulin-containing regimens (OR: 2.8; P = 0.015), higher BMI (OR: 1.1; P = 0.002), and elevated preoperative HbA1c (OR: 1.3; P = 0.049) predicted SSI following THA. No significant predictors of SSI after TKA were found, and medication regimen was not associated with revision risk. CONCLUSION: Patients with T2DM on insulin-containing regimens exhibited worse perioperative glycemic control and increased SSI incidence after THA, although medication regimen did not affect outcomes after TKA. Our findings are the first to suggest that insulin requirements in patients with T2DM, independent of glycemic control measured with preoperative HbA1c, may influence infection risk following THA and complicate perioperative glycemic control after TJA. We emphasize the importance of perioperative optimization and proactive management of these higher-risk patients, regardless of their preoperative HbA1c.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- New York University Langone Orthopedic Hospital, New York, USA.
- New York University Langone Orthopedic Hospital, New York, USA. Joshua.Rozell@nyulangone.org.
Zitieren
APA
Ruff, G., S Antonioli, S., Cordero, J., Cohen-Rosenblum, A., Schwarzkopf, R., & C Rozell, J. (2025). Anti-diabetic medications’ effect on outcomes and glycemic markers following TJA in patients with type 2 diabetes. Archives of Orthopaedic and Trauma Surgery. https://doi.org/10.1007/s00402-025-06160-9
Vancouver
Ruff G, S Antonioli S, Cordero J, Cohen-Rosenblum A, Schwarzkopf R, C Rozell J. Anti-diabetic medications’ effect on outcomes and glycemic markers following TJA in patients with type 2 diabetes. Archives of Orthopaedic and Trauma Surgery. 2025. doi:10.1007/s00402-025-06160-9
BibTeX
@article{Ruff2025,
author = {Ruff, Garrett and S Antonioli, Sophia and Cordero, John and Cohen-Rosenblum, Anna and Schwarzkopf, Ran and C Rozell, Joshua},
title = {Anti-diabetic medications’ effect on outcomes and glycemic markers following TJA in patients with type 2 diabetes},
journal = {Archives of Orthopaedic and Trauma Surgery},
year = {2025},
doi = {10.1007/s00402-025-06160-9}
}
EUVIMED